MORPHINE SULFATE 10 mg/1 mL MEDSURGE morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 10 mg/1 ml medsurge morphine sulfate pentahydrate 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 30 mg/1 mL MEDSURGE morphine sulfate pentahydrate 30 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 30 mg/1 ml medsurge morphine sulfate pentahydrate 30 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 2 mg/1 mL MEDSURGE morphine sulfate pentahydrate 2 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 2 mg/1 ml medsurge morphine sulfate pentahydrate 2 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 2 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 15 mg/1 mL MEDSURGE morphine sulfate pentahydrate 15 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 15 mg/1 ml medsurge morphine sulfate pentahydrate 15 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 15 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 5 mg/1 mL MEDSURGE morphine sulfate pentahydrate 5 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 5 mg/1 ml medsurge morphine sulfate pentahydrate 5 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE MR MYLAN morphine sulfate pentahydrate 10 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 10 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE SULFATE 10 mg/1 mL MEDICIANZ morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

morphine sulfate 10 mg/1 ml medicianz morphine sulfate pentahydrate 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

ARX MORPHINE MR morphine sulfate pentahydrate 10 mg modified release tablet blister packs Australia - English - Department of Health (Therapeutic Goods Administration)

arx morphine mr morphine sulfate pentahydrate 10 mg modified release tablet blister packs

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE LUPIN MR morphine sulfate pentahydrate 10 mg modified release tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

morphine lupin mr morphine sulfate pentahydrate 10 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

DEPODUR morphine sulfate pentahydrate 10 mg/1 mL suspension for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

depodur morphine sulfate pentahydrate 10 mg/1 ml suspension for injection vial

aspen pharmacare australia pty ltd - morphine sulfate pentahydrate, quantity: 10 mg/ml - injection, suspension - excipient ingredients: dioleoylphosphatidylcholine; dipalmitoylphosphatidylglycerol; cholesterol; triolein; tricaprylin; sodium chloride; dilute hydrochloric acid; water for injections - for the relief of post-operative pain following major orthopaedic, abdominal, or pelvic surgery via the lumbar epidural route at a maximum recommended dose of 10 mg. appropriate monitoring must be maintained for at least 48 hours - see precautions.